BYZOR Trademark

Trademark Overview


On Wednesday, March 27, 2013, a trademark application was filed for BYZOR with the United States Patent and Trademark Office. The USPTO has given the BYZOR trademark a serial number of 85888129. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 6, 2014. This trademark is owned by Glaxo Group Limited. The BYZOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
byzor

General Information


Serial Number85888129
Word MarkBYZOR
Filing DateWednesday, March 27, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 6, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BYZOR" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, October 6, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 6, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 17, 2014EXTENSION 1 GRANTED
Monday, February 17, 2014EXTENSION 1 FILED
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, September 3, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2013PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 3, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 3, 2013ASSIGNED TO EXAMINER
Tuesday, April 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 30, 2013NEW APPLICATION ENTERED IN TRAM